SpringerLink
Log in

Current Approaches to the Management of Oral Mucositis

  • Chapter
Oral Mucositis

  • 1714 Accesses

Abstract

Despite its frequency, impact on patients and health and economic costs, there are currently limited evidence-based options for the prevention or treatment of OM. A number of guidelines for the management of OM have been thoughtfully prepared by the Multinational Association of Supportive Care in Cancer (MASCC), the American Society of Clinical Oncology (ASCO), and the National Comprehensive Cancer Network (NCCN) panels. For the most part, they are in agreement. This chapter attempts to summarize the current standard of care for mucositis management in a way that presents a consensus of current recommendations.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 49.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free ship** worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  1. Keefe DM, Schubert MM, Elting LS, et al. Updated clinical practice guidelines for the prevention and treatment of mucositis. Cancer. 2007;109:820-831.

    Google Scholar 

  2. Hensley ML, Hagerty KL, Kewalramani T, et al. American Society of Clinical Oncolog y 2008 clinical practice guideline update: Use of chemotherapy and radiation therapy protectants. J Clin Oncol. 2009;27:127-145.

    Google Scholar 

  3. Bensinger W, Schubert M, Ang KK, et al. NCCN Task Force Report: Prevention and management of mucositis in cancer care. J Natl Compr Canc Netw. 2008;6(suppl 1):S1-S21.

    Google Scholar 

  4. Djuric M, Hillier-Kolarov V, Belic A, Jankovic L. Mucositis prevention by improved dental care in acute leukemia patients. Support Care Cancer. 2006;14:137-146.

    Google Scholar 

  5. Schubert MM, Peterson DE, Lloid ME: Oral complications. In: Thomas ED, Blume KG, Forman SJ, eds. Hematopoietic Cell Transplantation, 2nd edn. Malden, MA: Blackwell Science Inc; 1999:751-763.

    Google Scholar 

  6. Scully C, Epstein J, Sonis S. Oral mucositis: a challenging complication of radiotherapy, chemotherapy, and radiochemotherapy. Part 2: diagnosis and management of mucositis. Head Neck. 2004;26:77-84.

    Google Scholar 

  7. Treister N, Sonis S. Oral mucositis. In: Ettinger DS, ed. Cancer and Drug Discovery Development: Supportive Care in Cancer Therapy. Totowa, NJ: Humana Press. 2008;193-211.

    Google Scholar 

  8. Spielberger R, Stiff P, Bensinger W, et al. Palifermin for oral mucositis after intensive therapy for hematologic cancers. N Engl J Med. 2004;351:2590-2598.

    Google Scholar 

  9. Wynn RB, Mehta V. Reduction of treatment breaks and radiation-induced esophagitis and pneumonitis using amifostine in unresectable non-small cell lung cancer patients receiving definitive concurrent chemotherapy and radiation therapy: a prospective community-based clinical trial. Sem Oncol. 2005;32(2 suppl 3):S99-104.

    Google Scholar 

  10. Bensadoun RJ, Schubert MM, Lalla RV, Keefe D. Amifostine in the management of radiationinduced and chemo-induced mucositis. Support Care Cancer. 2006;14:566-572.

    Google Scholar 

  11. Flook C, Calman F, Mant M, et al. GELCLAIRR vs benzydamine in a randomised controlled study in patients with oral mucositis due to radical radiotherapy. Support Care Cancer. 2005;13:443-444.

    Google Scholar 

  12. McKenzie M, Papish S, Hansen V, et al. A randomized open label trial comparing Gelclair with institutional standard magic mouthwash for the treatment of pain associated with radiation or chemotherapy induced mucositis. Support Cancer Care. 2006;14:641.

    Google Scholar 

  13. Short L, Fung D. Clinical effectiveness of Gelclair in the treatment of oral mucositis: a patient based questionnaire. Int J Paediatr Dent. 2008;18(suppl 1):14.

    Google Scholar 

  14. Liewer SE, Hecht KA, Smith CF, et al. GelclairR for the treatment of chemotherapy-induced stomatitis in transplant and hematology patients: an interim analysis. Blood. 2004;104: Abstract 5317.

    Google Scholar 

  15. De Cordi D, D’Andrea N, Giorgiutti A, Martina S. Gelclair: potentially an efficacious treatment for chemotherapy-induced mucositis. Presented at: Italian Anti-tumour League III Congress for Professional Oncology Nurses; October 10-12, 2001; Conegliano, Italy.

    Google Scholar 

  16. D’Andrea N, Giorgiutti E, De Cordi D, Piga A. Oral pharyngeal mucositis: Nursing assessment on the efficacy of a new treatment. Ann Oncol. 2003;14(suppl 4):iv97.

    Google Scholar 

  17. Bonassi L, Cotroneo G, Nastasi G. Treatment with gelclair in patients suffering grade III-IV oral mcositis: Efficacy and impact on quality of life (QOL). Ann Oncol. 2003;14(suppl 4):E38.

    Google Scholar 

  18. Lindsay G, Rushton R, Harris T, et al. The clinical effectiveness of Gelclair in the management of oral mucositis. Austral Nurs J. 2009;16:30-33.

    Google Scholar 

  19. Innocenti M, Moscatelli G, Lopez S. Efficacy of Gelclair in reducing pain in patients with oral lesions: Preliminary findings from an open pilot study. J Pain Symptom Manage. 2002;24:456-457.

    Google Scholar 

  20. Hita-Iglesias P, Torres-Lagares D, Gutierrez-Perez JL. Evaluation of the clinical behaviour of a polyvinylpyrrolidone and sodium hyalonurate gel (Gelclair) in patients subjected to surgical treatment with CO2 laser. Int J Oral Maxillofac Surg. 2006;35:514-517.

    Google Scholar 

  21. Berndtson M. A preliminary study of Orassist (Gelclair) in the management of oral mucositis. Swedish Hospital Dentistry. 2001;26:17-21.

    Google Scholar 

  22. Barber C, Powell R, Ellis A, Hewett J. Comparing pain control and ability to eat and drink with standard therapy vs Gelclair: a preliminary, double centre, randomised controlled trial on patients with radiotherapy-induced oral mucositis. Support Care Cancer. 2007;15:427-440.

    Google Scholar 

  23. McLean M. An Audit of the Efficacy of GelclairR for Mouth Pain in Patients Undergoing Radiotherapy or Chemotherapy. Presented as a poster at 2009 BAHNON congress, UK.

    Google Scholar 

  24. Gibson F, Donachie PHJ, Blandford E, et al. Efficacy of Gelclair in reducing the pain of oral mucositis. Presented at the 42nd Congress of the International Society of Paediatric Oncology, October 21-24th, 2010, Boston, Massachusetts, USA.

    Google Scholar 

  25. Wildfang I, Tschechne B, Borghardt J, et al. Oropharyngeal mucositis prophylaxis in combined radioimmunochemotherapy. J Clin Oncol. 2010; 28 (suppl): Abstract e19613.

    Google Scholar 

  26. Duckert A, et al. Management of oral mucositis (OM) with a muco-adhesive oral rinse: European clinical experience. Abstract presented at the European Society for Medical Oncology Congress, Milan, 8-12 October 2010.

    Google Scholar 

  27. Naidu M, Ramana GV, Ratnam, SV et al. A randomized, double-blind, parallel, placebocontrolled study to evaluate the efficacy of MF5232 (Mucotrol), a concentrated oral gel wafer, in the treatment of oral mucositis. Drugs RD. 2005;6:291-298.

    Google Scholar 

  28. Abraham J. Calcium phosphate mouth rinse for preventing oral mucositis. Commun Oncol. 2008;5:171-172.

    Google Scholar 

  29. Papas AS, Clark RE, Martuscelli G, et al. A prospective, randomized trial for the prevention of mucositis in patients undergoing hematopoietic stem cell transplantation. Bone Marrow Transplant. 2003;31:705-712.

    Google Scholar 

  30. Stokman M, Burlage F, Spijkervet F, et al. The effect of a calcium phosphate mouth rinse on chemo/radiation induced oral mucositis in head and neck cancer patients. Support Care Cancer. 2010;S3:S114.

    Google Scholar 

  31. Elting LS, Cooksley CD, Chambers MS, Garden AS. Risk, outcomes, and costs of radiationinduced oral mucositis among patients with head-and-neck malignancies. Int J Radiat Oncol Biol Phys. 2007;68:1110-1120.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Brigham and Women’s Hospital, Boston, MA, USA

    Stephen T. Sonis

Authors
  1. Stephen T. Sonis
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer Healthcare

About this chapter

Cite this chapter

Sonis, S.T. (2012). Current Approaches to the Management of Oral Mucositis. In: Oral Mucositis. Springer Healthcare, Tarporley. https://doi.org/10.1007/978-1-907673-46-7_9

Download citation

  • DOI: https://doi.org/10.1007/978-1-907673-46-7_9

  • Publisher Name: Springer Healthcare, Tarporley

  • Print ISBN: 978-1-908517-63-0

  • Online ISBN: 978-1-907673-46-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation